Palmitoyl Tetrapeptide-3 is used for its significant anti-periorbital edema (reducing under-eye puffiness), anti-inflammatory, and anti-glycation properties; it helps diminish dark circles, enhances skin’s tolerance to environmental stressors, and boosts defense against pollution. It delays and inhibits excessive interleukin production, thereby suppressing unnecessary or inappropriate inflammatory responses and glycation damage. In vitro studies show that Palmitoyl Tetrapeptide-3 reduces interleukin levels in a dose-dependent manner—up to 40% reduction at higher concentrations—and achieves an 86% reduction in interleukins when applied after UV radiation exposure. As a key component of Matrixyl 3000, it works synergistically with Palmitoyl Oligopeptide to stimulate connective tissue growth and boost collagen synthesis, enabling skin self-repair and regeneration. Additionally, it accelerates wound healing by promoting the expression of Granulocyte Chemotactic Protein-2 (GCP-2). Being a fragment of immunoglobulin IgG, it also contributes to immunomodulatory functions.